Skip to main content

Advertisement

Log in

Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Aromatase, a key enzyme in local estrogen synthesis, is expressed in different pituitary tumors including growth hormone (GH)-secreting adenomas. We aimed to evaluate aromatase, estrogen receptor α (ERα), estrogen receptor β (ERβ), pituitary tumor transforming gene (PTTG), and fibroblast growth factor 2 (FGF2) expressions in GH-secreting adenomas, and investigate their correlation with clinical, pathologic, and radiologic parameters. This cross-sectional study was conducted in a tertiary center in Turkey. Protein expressions were determined via immunohistochemical staining in ex vivo tumor samples of 62 patients with acromegaly and ten normal pituitary tissues. Concordantly increased aromatase, PTTG, and FGF2 expressions were detected in the tumor samples as compared with controls (p < 0.001 for all). None of the tumors expressed ERα while ERβ was detected only in mixed somatotroph adenomas. Aromatase, ERβ, PTTG expressions were not significantly different between patients with and without remission (p > 0.05 for all). FGF2 expression was significantly higher in patients without postoperative and late remission (p = 0.002 and p = 0.012, respectively), with sphenoid bone invasion, optic chiasm compression, and somatostatin analog resistance (p = 0.005, p = 0.033, and p = 0.013, respectively). Aromatase, PTTG and FGF2 expressions were positively correlated with each other (r = 0,311, p = 0.008 for aromatase, FGF2; r = 0.380, p = 0.001 for aromatase, PTTG; r = 0.400, p = 0.001 for FGF2, PTTG). PTTG-mediated FGF2 upregulation is associated with more aggressive tumor features in patients with acromegaly. Also, locally produced estrogen through aromatization might have a role in this phenomenon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. T. Minematsu, S. Miyai, H. Kajiya, M. Suzuki, N. Sanno, S. Takekoshi, A. Teramoto, R.Y. Osamura, Recent progress in studies of pituitary tumor pathogenesis. Endocrine 28(1), 37–41 (2005). doi:10.1385/endo:28:1:037

    Article  CAS  PubMed  Google Scholar 

  2. S. Melmed, Mechanisms for pituitary tumorigenesis: the plastic pituitary. J. Clin. Invest. 112(11), 1603–1618 (2003). doi:10.1172/jci20401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. M. Pawlikowski, Endocrine/paracrine control of pituitary cell proliferation and its involvement in pituitary tumorigenesis. Pituitary 1(3–4), 251–256 (1999). doi:10.1023/A:1009998207652

    Article  CAS  PubMed  Google Scholar 

  4. A.S. Caglar, A. Kapucu, K.A. Dar, H.M. Ozkaya, E. Caglar, H. Ince, P. Kadioglu, Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis. Endocrine (2015). doi:10.1007/s12020-015-0537-6

    Google Scholar 

  5. D. Avtanski, H.J. Novaira, S. Wu, C.J. Romero, R. Kineman, R.M. Luque, F. Wondisford, S. Radovick, Both estrogen receptor α and β stimulate pituitary GH gene expression. Mol. Endocrinol. 28(1), 40–52 (2014). doi:10.1210/me.2013-1245

    Article  PubMed  PubMed Central  Google Scholar 

  6. T. Spady, R. McComb, J. Shull, Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland. Endocrine 11(3), 217–233 (1999). doi:10.1385/ENDO:11:3:217

    Article  CAS  PubMed  Google Scholar 

  7. F. Salehi, K. Kovacs, B.W. Scheithauer, R.V. Lloyd, M. Cusimano, Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update. Endocr. Relat. Cancer 15(3), 721–743 (2008). doi:10.1677/erc-08-0012

    Article  CAS  PubMed  Google Scholar 

  8. C.J. McCabe, A.P. Heaney, Pituitary tumour transforming gene in endocrine cancer. Clin. Endocrinol. 58(6), 673–682 (2003). doi:10.1046/j.1365-2265.2003.01687.x

    Article  CAS  Google Scholar 

  9. T.R. Prezant, P. Kadioglu, S. Melmed, An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family. J. Clin. Endocrinol. Metab. 84(3), 1149–1152 (1999). doi:10.1210/jcem.84.3.5658

    Article  CAS  PubMed  Google Scholar 

  10. A.J. Weissberger, K.K. Ho, Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization. J. Clin. Endocrinol. Metab. 76(6), 1407–1412 (1993). doi:10.1210/jcem.76.6.8501143

    CAS  PubMed  Google Scholar 

  11. M. Iruthayanathan, Y.H. Zhou, G.V. Childs, Dehydroepiandrosterone restoration of growth hormone gene expression in aging female rats, in vivo and in vitro: evidence for actions via estrogen receptors. Endocrinology 146(12), 5176–5187 (2005). doi:10.1210/en.2005-0811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. J. Carretero, G. Vazquez, E. Blanco, M. Rubio, M. Santos, A. Martin-Clavijo, J.L. Torres, R. Vazquez, Immunohistochemical evidence of the presence of aromatase P450 in the rat hypophysis. Cell Tissue Res. 295(3), 419–423 (1999)

    Article  CAS  PubMed  Google Scholar 

  13. J. Carretero, D.J. Burks, G. Vazquez, M. Rubio, E. Hernandez, P. Bodego, R. Vazquez, Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Pituitary 5(1), 5–10 (2002)

    Article  CAS  PubMed  Google Scholar 

  14. P. Kadioglu, G. Oral, M. Sayitoglu, N. Erensoy, B. Senel, N. Gazioglu, A. Sav, G. Cetin, U. Ozbek, Aromatase cytochrome P450 enzyme expression in human pituitary. Pituitary 11(1), 29–35 (2008). doi:10.1007/s11102-007-0065-3

    Article  CAS  PubMed  Google Scholar 

  15. H. Akinci, A. Kapucu, K.A. Dar, O. Celik, B. Tutunculer, G. Sirin, B. Oz, N. Gazioglu, H. Ince, S. Aliustaoglu, P. Kadioglu, Aromatase cytochrome P450 enzyme expression in prolactinomas and its relationship to tumor behavior. Pituitary 16(3), 386–392 (2013). doi:10.1007/s11102-012-0436-2

    Article  CAS  PubMed  Google Scholar 

  16. A. Selek, B. Cetinarslan, Y. Gurbuz, I. Tarkun, Z. Canturk, B. Cabuk, Aromatase enzyme expression in acromegaly and its possible relationship with disease prognosis. Endocrine 49(1), 250–257 (2015). doi:10.1007/s12020-014-0445-1

    Article  CAS  PubMed  Google Scholar 

  17. P.H. Gonzales, L.C. Mezzomo, N.P. Ferreira, A.V. Roehe, M.B. Kohek, C. Oliveira, Mda, Aromatase P450 expression in human pituitary adenomas. Neuropathology 35(1), 16–23 (2015). doi:10.1111/neup.12145

    Article  CAS  PubMed  Google Scholar 

  18. E. Hatipoglu, S. Bozcan, P. Kadioglu, Discontinuation of somatostatin analogs while acromegaly is in long-term remission. Pituitary 18(4), 554–560 (2015). doi:10.1007/s11102-014-0608-3

    Article  CAS  PubMed  Google Scholar 

  19. L. Katznelson, E.R. Laws Jr, S. Melmed, M.E. Molitch, M.H. Murad, A. Utz, J.A. Wass, Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–3951 (2014). doi:10.1210/jc.2014-2700

    Article  CAS  PubMed  Google Scholar 

  20. A. Colao, R.S. Auriemma, G. Lombardi, R. Pivonello, Resistance to somatostatin analogs in acromegaly. Endocr. Rev. 32(2), 247–271 (2011). doi:10.1210/er.2010-0002

    Article  CAS  PubMed  Google Scholar 

  21. V. Birzniece, A. Sata, S. Sutanto, K.K. Ho, Paracrine regulation of growth hormone secretion by estrogen in women. J. Clin. Endocrinol. Metab. 95(8), 3771–3776 (2010). doi:10.1210/jc.2010-0476

    Article  CAS  PubMed  Google Scholar 

  22. G. Vlotides, T. Eigler, S. Melmed, Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr. Rev. 28(2), 165–186 (2007). doi:10.1210/er.2006-0042

    Article  CAS  PubMed  Google Scholar 

  23. X. Zhang, G.A. Horwitz, A.P. Heaney, M. Nakashima, T.R. Prezant, M.D. Bronstein, S. Melmed, Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J. Clin. Endocrinol. Metab. 84(2), 761–767 (1999). doi:10.1210/jcem.84.2.5432

    Article  CAS  PubMed  Google Scholar 

  24. C.J. McCabe, J.S. Khaira, K. Boelaert, A.P. Heaney, L.A. Tannahill, S. Hussain, R. Mitchell, J. Olliff, M.C. Sheppard, J.A. Franklyn, N.J. Gittoes, Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin. Endocrinol. (Oxf) 58(2), 141–150 (2003)

    Article  CAS  Google Scholar 

  25. M. Filippella, F. Galland, M. Kujas, J. Young, A. Faggiano, G. Lombardi, A. Colao, G. Meduri, P. Chanson, Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study. Clin. Endocrinol. (Oxf) 65(4), 536–543 (2006). doi:10.1111/j.1365-2265.2006.02630.x

    Article  Google Scholar 

  26. F. Salehi, K. Kovacs, B.W. Scheithauer, D. Cantelmi, E. Horvath, R.V. Lloyd, M. Cusimano, Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes. Int. J. Surg. Pathol. 18(1), 5–13 (2010). doi:10.1177/1066896909356105

    Article  PubMed  Google Scholar 

  27. T. Minematsu, N. Egashira, H. Kajiya, M. Takei, S. Takekoshi, Y. Itoh, H. Tsukamoto, J. Itoh, N. Sanno, A. Teramoto, R.Y. Osamura, PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines. Endocr. Pathol. 18(1), 8–15 (2007)

    Article  CAS  PubMed  Google Scholar 

  28. A. Wierinckx, C. Auger, P. Devauchelle, A. Reynaud, P. Chevallier, M. Jan, G. Perrin, M. Fèvre-Montange, C. Rey, D. Figarella-Branger, G. Raverot, M.-F. Belin, J. Lachuer, J. Trouillas, A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr. Relat. Cancer 14(3), 887–900 (2007). doi:10.1677/erc-07-0062

    Article  CAS  PubMed  Google Scholar 

  29. A.P. Heaney, G.A. Horwitz, Z. Wang, R. Singson, S. Melmed, Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat. Med. 5(11), 1317–1321 (1999). doi:10.1038/15275

    Article  CAS  PubMed  Google Scholar 

  30. K. Chamaon, D. Kanakis, C. Mawrin, K. Dietzmann, E. Kirches, Transcripts of PTTG and growth factors bFGF and IGF-1 are correlated in pituitary adenomas. Exp. Clin. Endocrinol. Diabetes 118(2), 121–126 (2010). doi:10.1055/s-0029-1215588

    Article  CAS  PubMed  Google Scholar 

  31. A.P. Heaney, M. Fernando, S. Melmed, Functional role of estrogen in pituitary tumor pathogenesis. J. Clin. Invest. 109(2), 277–283 (2002). doi:10.1172/jci14264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Y. Lu, M. You, Z. Ghazoui, P. Liu, P.T. Vedell, W. Wen, A.M. Bode, C.J. Grubbs, R.A. Lubet, Concordant effects of aromatase inhibitors on gene expression in ER + Rat and human mammary cancers and modulation of the proteins coded by these genes. Cancer Prev. Res. 6(11), 1151–1161 (2013). doi:10.1158/1940-6207.capr-13-0126

    Article  CAS  Google Scholar 

  33. M. Schmidt, G. Löffler, Induction of aromatase in stromal vascular cells from human breast adipose tissue depends on cortisol and growth factors. FEBS Lett. 341(2–3), 177–181 (1994). doi:10.1016/0014-5793(94)80452-4

    Article  CAS  PubMed  Google Scholar 

  34. K. Gill, N. Kirma, R.R. Tekmal, Overexpression of aromatase in transgenic male mice results in the induction of gynecomastia and other biochemical changes in mammary glands. J. Steroid Biochem. Mol. Biol. 77(1), 13–18 (2001)

    Article  CAS  PubMed  Google Scholar 

  35. G. Vlotides, Y.H. Chen, T. Eigler, S.G. Ren, S. Melmed, Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells. Endocrinology 150(7), 3252–3258 (2009). doi:10.1210/en.2008-1625

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. S. Oomizu, K. Chaturvedi, D.K. Sarkar, Folliculostellate cells determine the susceptibility of lactotropes to estradiol’s mitogenic action. Endocrinology 145(3), 1473–1480 (2004). doi:10.1210/en.2003-0965

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. H.B. Fokidis, H.H. Adomat, G. Kharmate, E. Hosseini-Beheshti, E.S. Guns, K.K. Soma, Regulation of local steroidogenesis in the brain and in prostate cancer: lessons learned from interdisciplinary collaboration. Front. Neuroendocrinol. 36, 108–129 (2015). doi:10.1016/j.yfrne.2014.08.005

    Article  CAS  PubMed  Google Scholar 

  38. B. Filova, M. Malinova, J. Babickova, L. Tothova, D. Ostatnikova, P. Celec, J. Hodosy, Effects of testosterone and estradiol on anxiety and depressive-like behavior via a non-genomic pathway. Neurosci. Bull. 31(3), 288–296 (2015). doi:10.1007/s12264-014-1510-8

    Article  CAS  PubMed  Google Scholar 

  39. T. Suzuki, H. Sasano, H. Sasaki, T. Fukaya, H. Nagura, Quantitation of P450 aromatase immunoreactivity in human ovary during the menstrual cycle: relationship between the enzyme activity and immunointensity. J. Histochem. Cytochem. 42(12), 1565–1573 (1994)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study did not receive any specific grants from any funding agencies in the public, commercial, or not-for-profit sector.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pinar Kadioglu.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozkaya, H.M., Comunoglu, N., Keskin, F.E. et al. Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas. Endocrine 52, 632–640 (2016). https://doi.org/10.1007/s12020-015-0802-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0802-8

Keywords

Navigation